TipRanks

Michael Egholm Insider Profile

4 Followers
Michael Egholm, President & CEO, Director at Standard BioTools, holds 6.14M shares in Standard BioTools (Ticker: LAB), holds ― shares in IsoPlexis (Ticker: ISO), holds 0.00 shares in Pall Corp (Ticker: ~PLL).
tipranks
Michael Egholm

Michael Egholm
Standard BioTools (LAB)
President & CEO, Director

Ranked #61,835 out of 109,287 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-5.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
A breakdown of Michael Egholm's holdings

Insider Roles

Standard BioTools
(LAB)
President & CEO, Director
Roles that Michael Egholm holds in companies

Most Profitable Insider Trade

Stock:
Standard BioTools
(LAB)
Rating:Informative Sell
Date:May 27, 2025 - May 27, 2026
Return:-2.90%
The most profitable trade made by Michael Egholm

Michael Egholm's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Standard BioTools
Aug 24, 2026
President & CEO, Director
Uninformative Sell
65.41K
$3.90M
ISO
IsoPlexis
―
―
―
―
~PLL
Pall Corp
Aug 31, 2015
―
Uninformative Sell
3.64M
$0.00
List of latest transactions for each holding click on a transaction to see Michael Egholm's performance on stock

Michael Egholm insider profile FAQ

What is the percentage of profitable transactions made by Michael Egholm?
The percentage of profitable transactions made by Michael Egholm is 0%.
    What is the average return per transaction made by Michael Egholm?
    The average return per transaction made by Michael Egholm is -5.10%.
      What stocks does Michael Egholm hold?
      Michael Egholm holds: LAB, ISO, ~PLL stocks.
        What was Michael Egholm’s latest transaction?
        Michael Egholm latest transaction was an Uninformative Sell of $65.41K.
          What was Michael Egholm's most profitable transaction?
          Michael Egholm’s most profitable transaction was an Informative Sell of LAB stock on May 27, 2025. The return on the trade was -2.90%.
            What is Michael Egholm's role in Standard BioTools?
            Michael Egholm's role in Standard BioTools is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.